GL1X · GenesisL1 explorer

Research workbench

Replacements of PRO86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability

Analyse Replacements of PRO86 in phage T4 lysozyme extend an alpha-helix but do not… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1L29
Type
protein
Length
164 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
T4 lysozyme
EC
3.2.1.17
UniProt
P00720
Pockets
1 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 67% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AT4 lysozyme (EC 3.2.1.17)protein16467% helix, 9% strandP00720

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12740.540.7633empty

Compared structures

  • 1L29 · Replacements of PRO86 in phage T4 lysozyme extend an alpha-helix but do not alter protein… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.